Andrew Combs
Corporate Officer/Principal at PRELUDE THERAPEUTICS INCORPORATED
Net worth: - $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Krishna Vaddi | M | 58 | 22 years | |
| Bryant Lim | M | 53 | 6 years | |
| Herve Hoppenot | M | 64 | 10 years | |
| Paul Friedman | M | 81 |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 13 years |
| Aimee Crombie | M | - | 6 years | |
| Victor Sandor | M | 57 | 14 years | |
| Thomas Tray | M | 46 | 19 years | |
| Jane Huang | M | 51 | 2 years | |
| Peggy Scherle | M | 62 | 22 years | |
| Julian Baker | M | 57 | 3 years | |
| Martin Babler | M | 59 | 3 years | |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Jean-Jacques Bienaimé | M | 70 | 9 years | |
| David Bonita | M | 48 | 8 years | |
| Paul Clancy | M | 62 | 9 years | |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Mardi Dier | F | 60 | 4 years | |
| Catalina Loveman | F | - | 9 years | |
| Vijay Iyengar | M | 51 | 8 years | |
| Michael Morrissey | M | - | 8 years | |
| Barry Flannelly | M | 66 | 10 years | |
| Peter Langmuir | M | - | 9 years | |
| Lothar H. Finke | M | - | 7 years | |
| Madhu Pudipeddi | M | - | - | |
| Michele Porreca | F | - | 3 years | |
| Wan-Jen Hong | M | 45 | - | |
| Steven Stein | M | 57 | 9 years | |
| Lindsey Trickett | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roy Whitfield | M | 70 | 23 years | |
| Laurent Chardonnet | M | 59 | 3 years | |
| Richard de Schutter | M | 83 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 14 years |
| Robert Stein | M | 73 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 7 years |
| Richard Levy | M | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 19 years |
| Reid Huber | M | 52 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 20 years |
| Steve Friedman | M | 78 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 5 years |
| Elias Bendekgey | M | 66 | 6 years | |
| Osagie Imasogie | M | 62 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 2 years |
| David Hastings | M | 62 | 11 years | |
| Barry Michael Ariko | M | 78 | 14 years | |
| Scott W. Hurley | M | 65 | - | |
| Joseph Papa | M | 68 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Paula Swain | F | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 10 years |
| Rosemary Crane | F | 64 | 20 years | |
| Stacey L. Jurchison | F | - | 3 years | |
| Laurent Fischer | M | 60 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 2 years |
| Michael Charles A. Booth | M | 53 | 7 years | |
| Eric Siegel | M | 60 | - | |
| Rebecca Taub | M | 71 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 3 years |
| Paul S. Anderson | M | 85 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 4 years |
| John F. Niblack | M | 85 | - | |
| Maria Pasquale | F | 58 | 5 years | |
| Timothy Meeker | M | 77 | 13 years | |
| Wenqing Yao | M | 61 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 6 years |
| Wendy Dixon | M | 68 | 12 years | |
| Audrey F. Jakubowski | M | 81 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | 7 years |
| Patricia A. Schreck | F | 70 | 8 years | |
| Paul Trower | M | 54 | 18 years | |
| Peter Nicklin | M | 61 | 14 years | |
| Dale Kummerle | M | - | 17 years | |
| Jin Jin Liang | M | 55 | 3 years | |
| Enrique Sendagorta Gomendio | M | - | - | |
| James E. Foley | M | - | - | |
| Robert Roche | M | 57 | 6 years | |
| Georgia Keresty | M | 62 | 4 years | |
| Paul Biondi | M | 54 | - | |
| Arturo O. Araya | M | 53 | 3 years | |
| Karen Smith | M | 56 | 5 years | |
| Miguel Forte | M | 63 | 5 years | |
| Thomas J. McKearn | M | 75 | 10 years | |
| Christopher Bowden | M | 63 | 3 years | |
| Robert W. Morrissey | M | 66 | 6 years | |
| Douglas C. Plessinger | M | 55 | 6 years | |
| Robert Martell | M | 61 | 3 years | |
| Rajesh K. Malik | M | 65 | 2 years | |
| Stéphane Thiroloix | M | - | - | |
| Kimberly A. Hendricks | F | 60 | 3 years | |
| Beth Seidenberg | M | 67 | 2 years | |
| Steven E. Benner | M | 64 | 7 years | |
| Matthew Emmens | M | 72 | 3 years | |
| John F. Bedard | M | 74 | - | |
| Fabio M. Benedetti | M | 58 | 3 years | |
| Richard L. Wolgemuth | M | 78 | - | |
| David K. Bol | M | 58 | 6 years | |
| Faheem Hasnain | M | 65 | 2 years | |
| Bruce Wendel | M | 70 | 14 years | |
| Michael A. Popson | M | - | 6 years | |
| Andrew Shenker | M | 69 | 5 years | |
| Roger Theodoredis | M | 65 | 3 years | |
| Freda Lewis-Hall | M | 69 | 5 years | |
| Daniel M. Bollag | M | 63 | 2 years | |
| Andrew Bonfield | M | 61 | 5 years | |
| Marino Carol | F | - | 8 years | |
| William P. Keane | M | 68 | 1 years | |
| David Apelian | M | 59 | 2 years | |
| Alejandro A. Aruffo | M | 63 | 1 years | |
| Hemanshu Shah | M | 63 | 14 years | |
| Robert Hopfner | M | 51 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | - |
| Emma Reeve | F | 63 | 8 years | |
| debra j bass | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Combs
- Personal Network
